X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-05 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $225.00 | -8,000 | 52,773 | -13% | -$1,800,000 | ||||||
| D | 2026-08-03 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $18.46 | -20,000 | 97,130 | -17% | -$369,214 | |||||
| M | 2026-08-03 | SI | Shoulder Innovations, Inc. | Gilde Healthcare Holding B.V. | 10% | S - Sale | $22.76 | -110,563 | 2,221,640 | -5% | -$2,516,874 | |||||
| M | 2026-08-03 | ANIK | Anika Therapeutics, Inc. | Fischetti Gary P | Dir | P - Purchase | $20.53 | +2,000 | 54,015 | +4% | +$41,060 | |||||
| M | 2026-08-03 | BSX | Boston Scientific Corp | Habiger David C | Dir | P - Purchase | $48.13 | +1,182 | 15,060 | +9% | +$56,887 | |||||
2026-08-03 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | P - Purchase | $48.33 | +186,240 | 1,612,143 | +13% | +$9,001,408 | ||||||
| M | 2026-08-03 | PFSA | Profusa, Inc. | Hrt Financial LP | 10% | P - Purchase | $0.96 | +15,924 | 109,669 | +17% | +$15,250 | |||||
| D | 2026-08-04 | MMSI | Merit Medical Systems Inc | Peterson Neil W. | COO | S - Sale+OE | $85.00 | -21,449 | 25,551 | -46% | -$1,823,165 | |||||
2026-08-03 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $4.09 | -15,000 | 1,154,327 | -1% | -$61,350 | ||||||
| M | 2026-07-31 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $82.66 | -4,000 | 55,183 | -7% | -$330,640 | |||||
2026-08-03 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $122.12 | -617 | 22,410 | -3% | -$75,349 | ||||||
2026-08-03 | IRTC | Irhythm Holdings, Inc. | Rodda Julianne | EVP, CHIEF PEOPLE OFFICER | S - Sale | $122.12 | -2,112 | 18,201 | -10% | -$257,919 | ||||||
2026-08-03 | IRTC | Irhythm Holdings, Inc. | Patterson Chad | CHIEF COMM, PRODUCT OFFICER | S - Sale | $122.12 | -2,712 | 55,629 | -5% | -$331,192 | ||||||
| M | 2026-07-30 | KMTS | Kestra Medical Technologies, Ltd. | Moran Timothy P. | Chief Business Officer | S - Sale | $22.83 | -15,256 | 66,345 | -19% | -$348,311 | |||||
| M | 2026-07-30 | KMTS | Kestra Medical Technologies, Ltd. | Ford Alfred J Jr | Chief Commercial Officer | S - Sale | $23.25 | -27,632 | 105,839 | -21% | -$642,523 | |||||
| M | 2026-07-30 | KMTS | Kestra Medical Technologies, Ltd. | Mahboob Vaseem | CFO | S - Sale | $22.99 | -18,188 | 93,891 | -16% | -$418,217 | |||||
| M | 2026-07-30 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | S - Sale | $23.07 | -22,229 | 199,405 | -10% | -$512,791 | |||||
| M | 2026-07-30 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $23.21 | -29,822 | 527,115 | -5% | -$692,214 | |||||
| M | 2026-07-30 | SI | Shoulder Innovations, Inc. | Gilde Healthcare Holding B.V. | 10% | S - Sale | $23.10 | -48,279 | 2,332,203 | -2% | -$1,115,176 | |||||
2026-07-31 | GKOS | Glaukos Corp | Wen Leana | Dir | S - Sale | $167.63 | -525 | 21,092 | -2% | -$88,006 | ||||||
2026-07-31 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | P - Purchase | $45.48 | +5,000 | 30,359 | +20% | +$227,400 | ||||||
| M | 2026-07-30 | PFSA | Profusa, Inc. | Hrt Financial LP | 10% | P - Purchase | $1.05 | +9,874 | 93,745 | +12% | +$10,325 | |||||
| D | 2026-07-29 | XAIR | Beyond Air, Inc. | Goodman Robert Scott | CEO | P - Purchase | $5.76 | +34,722 | 34,822 | >999% | +$199,999 | |||||
| D | 2026-07-29 | XAIR | Beyond Air, Inc. | Moorhead Daniel J | CFO | P - Purchase | $5.76 | +4,340 | 4,340 | New | +$24,998 | |||||
2026-07-30 | ANGO | Angiodynamics Inc | Nighan Warren Jr | SVP Quality, Regulatory | S - Sale | $14.72 | -23,370 | 64,745 | -27% | -$344,006 | ||||||
2026-07-28 | ATRC | Atricure, Inc. | Doraiswamy Vinayak | Chief Scientific Officer | S - Sale | $38.88 | -6,000 | 86,511 | -6% | -$233,280 | ||||||
| D | 2026-07-28 | ATRC | Atricure, Inc. | Wehrwein Sven | Dir | S - Sale+OE | $37.84 | -25,000 | 40,518 | -38% | -$946,000 | |||||
2026-07-29 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $38.80 | -6,182 | 100,219 | -6% | -$239,862 | ||||||
2026-07-29 | PFSA | Profusa, Inc. | Hrt Financial LP | 10% | P - Purchase | $1.01 | +1,310 | 83,871 | +2% | +$1,323 | ||||||
| D | 2026-07-23 | DRIO | Dariohealth Corp. | Matheis Dennis | Dir | P - Purchase | $6.93 | +14,430 | 43,026 | +50% | +$100,000 | |||||
2026-07-27 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $157.13 | -75 | 20,934 | 0% | -$11,785 | ||||||
2026-07-23 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale | $169.42 | -924 | 3,189 | -22% | -$156,544 | ||||||
| D | 2026-07-23 | MMM | 3M Co | Banovetz John Patrick | EVP | S - Sale+OE | $170.44 | -7,880 | 50,057 | -14% | -$1,343,067 | |||||
| D | 2026-07-22 | MMM | 3M Co | Rhodes Kevin H | EVP, Chief Legal Off, Secret | S - Sale+OE | $171.20 | -7,669 | 43,780 | -15% | -$1,312,933 | |||||
| D | 2026-07-22 | MMM | 3M Co | Goralski Christian T Jr | Group Pres | S - Sale+OE | $170.46 | -4,902 | 6,971 | -41% | -$835,577 | |||||
| M | 2026-07-21 | RDGL | Vivos Inc | Weeks Brad Allan | Pres | P - Purchase | $0.05 | +92,000 | 1,471,654 | +7% | +$4,600 | |||||
2026-07-20 | DXCM | Dexcom Inc | Sayer Kevin R | Exec Chair | S - Sale | $76.32 | -26,756 | 328,970 | -8% | -$2,041,999 | ||||||
| D | 2026-07-16 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale+OE | $160.00 | -10,000 | 43,906 | -19% | -$1,600,000 | |||||
2026-07-16 | CERS | Cerus Corp | Jayaraman Vivek K | CEO | S - Sale | $3.16 | -16,666 | 2,232,211 | -1% | -$52,665 | ||||||
| D | 2026-07-15 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $25.72 | -9,219 | 234,271 | -4% | -$237,113 | |||||
2026-07-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $22.44 | -15,000 | 556,937 | -3% | -$336,609 | ||||||
2026-07-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP Chief Legal Compliance Off | S - Sale | $74.42 | -1,700 | 104,653 | -2% | -$126,514 | ||||||
| AM | 2026-07-09 | RDGL | Vivos Inc | Weeks Brad Allan | Pres | P - Purchase | $0.08 | +60,000 | 1,379,654 | +5% | +$4,800 | |||||
2026-07-15 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +200,000 | 11,285,090 | +2% | +$11,420 | ||||||
2026-07-14 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.78 | +35,000 | 10,588,988 | 0% | +$62,300 | ||||||
2026-03-16 | PDEX | Pro Dex Inc | Domingo Angelita Rebamontan | Dir | S - Sale | $47.24 | -998 | 18,779 | -5% | -$47,146 | ||||||
2026-07-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $27.75 | -22,562 | 435,373 | -5% | -$626,096 | ||||||
| D | 2026-07-09 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale+OE | $155.00 | -10,000 | 43,681 | -19% | -$1,550,000 | |||||
2026-07-09 | BJDX | Bluejay Diagnostics, Inc. | Hrt Financial LP | 10% | P - Purchase | $1.51 | +64,047 | 92,055 | +229% | +$96,711 | ||||||
2026-07-10 | BJDX | Bluejay Diagnostics, Inc. | Hrt Financial LP | 10% | S - Sale | $1.40 | -34,938 | 92,055 | -28% | -$48,913 | ||||||
| M | 2026-07-09 | RDGL | Vivos Inc | Weeks Brad Allan | Pres | P - Purchase | $0.08 | +60,000 | 999,235 | +6% | +$4,800 | |||||
| D | 2026-07-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $218.55 | -4,991 | 468,313 | -1% | -$1,090,771 | |||||
| D | 2026-07-06 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale+OE | $150.00 | -10,000 | 43,681 | -19% | -$1,500,000 | |||||
2026-07-01 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $139.06 | -716 | 87,634 | -1% | -$99,567 | ||||||
2026-07-06 | DXCM | Dexcom Inc | Sayer Kevin R | Exec Chair | S - Sale | $72.00 | -26,756 | 355,726 | -7% | -$1,926,432 | ||||||
2026-07-06 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $14.00 | -2,270 | 90,180 | -2% | -$31,782 | ||||||
2026-07-06 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $5.51 | -12,733 | 357,037 | -3% | -$70,133 | ||||||
2026-07-02 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $5.36 | -6,902 | 224,037 | -3% | -$36,995 | ||||||
2026-07-06 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.51 | -7,418 | 1,982,872 | 0% | -$40,858 | ||||||
2026-07-01 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $5.42 | -2,829 | 264,978 | -1% | -$15,333 | ||||||
2026-07-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $5.36 | -24,184 | 664,709 | -4% | -$129,626 | ||||||
2026-07-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $5.42 | -28,684 | 6,122,472 | 0% | -$155,467 | ||||||
2026-07-02 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $16.71 | -3,134 | 277,375 | -1% | -$52,375 | ||||||
2026-07-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $16.77 | -3,317 | 256,560 | -1% | -$55,627 | ||||||
2026-07-02 | IRTC | Irhythm Holdings, Inc. | Turakhia Minang | CHIEF MED, SCI OFCR EVP ADVTEC | S - Sale | $124.71 | -1,423 | 53,620 | -3% | -$177,462 | ||||||
2026-07-02 | IRTC | Irhythm Holdings, Inc. | Freeman Sean Clinton | EVP, Strategy, Corp Devt | S - Sale | $124.71 | -918 | 13,641 | -6% | -$114,484 | ||||||
2026-07-02 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $13.00 | -17,873 | 90,180 | -17% | -$232,397 | ||||||
2026-06-30 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $2.94 | -33,676 | 1,062,188 | -3% | -$99,105 | ||||||
| D | 2026-06-30 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $2.94 | -42,359 | 2,248,877 | -2% | -$124,658 | |||||
2026-06-30 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $2.94 | -24,329 | 966,657 | -2% | -$71,598 | ||||||
2026-06-30 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $2.94 | -101,919 | 5,053,036 | -2% | -$299,937 | ||||||
| ADM | 2026-06-26 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -10,000 | 166,053 | -6% | -$170,387 | |||||
2026-06-30 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Market Development Dir | S - Sale | $3.18 | -10,000 | 20,692 | -33% | -$31,773 | ||||||
2026-07-01 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $4.27 | -15,000 | 1,169,327 | -1% | -$64,050 | ||||||
2026-07-01 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $13.02 | -2,127 | 90,180 | -2% | -$27,691 | ||||||
| D | 2026-06-29 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $19.38 | -20,000 | 308,230 | -6% | -$387,600 | |||||
2026-06-30 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $12.00 | -20,000 | 90,180 | -18% | -$240,044 | ||||||
| DM | 2026-06-26 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -10,000 | 165,931 | -6% | -$170,387 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures - Houston, LLC | 10% | P - Purchase | $15.00 | +60,537 | 60,537 | New | +$908,055 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | P - Purchase | $15.00 | +33,333 | 311,112 | +12% | +$499,995 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | S - Sale+OE | $0.00 | -6,731 | 43,799 | -13% | -$0 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | P - Purchase | $15.00 | +81,000 | 81,000 | New | +$1,215,000 | |||||
2026-06-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $152.80 | -75 | 21,009 | 0% | -$11,460 | ||||||
2026-06-24 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $35.00 | -38,900 | 457,935 | -8% | -$1,361,500 | ||||||
2026-06-25 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $11.00 | -20,000 | 110,180 | -15% | -$220,004 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Balachandran Madhavan | Dir | S - Sale | $17.09 | -1,493 | 69,458 | -2% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Morel Donald E Jr | Dir | S - Sale | $17.09 | -1,493 | 37,424 | -4% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Flynn Karen | Dir | S - Sale | $17.09 | -1,493 | 5,757 | -21% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Federici William J | Dir | S - Sale | $17.09 | -1,493 | 58,580 | -2% | -$25,515 | ||||||
2026-06-24 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $15.01 | -1,258 | 129,354 | -1% | -$18,880 | ||||||
2026-06-24 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $15.00 | -1,406 | 25,994 | -5% | -$21,090 | ||||||
2026-06-23 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $9.55 | -17,500 | 130,180 | -12% | -$167,051 | ||||||
2026-06-24 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale | $145.66 | -1,100 | 13,172 | -8% | -$160,226 | ||||||
| M | 2026-06-18 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.59 | -11,000 | 322,692 | -3% | -$6,519 | |||||
2026-06-17 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.05 | +880,456 | 123,944 | -116% | +$40,501 | ||||||
2026-06-18 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $3.87 | -136,665 | 123,944 | -52% | -$528,894 | ||||||
2026-06-18 | OFIX | Orthofix Medical Inc. | McPherron Aviva | Pres, Global Ops, Qual | S - Sale | $9.38 | -3,670 | 66,330 | -5% | -$34,425 | ||||||
| D | 2026-06-17 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $17.79 | -61,843 | 308,230 | -17% | -$1,100,463 | |||||
| D | 2026-06-15 | BWAY | Brainsway Ltd. | Moiseyev Gilad | CTO | S - Sale+OE | $0.00 | -5,000 | 53,098 | -9% | -$0 | |||||
2026-06-16 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $130.68 | -1,537 | 88,833 | -2% | -$200,855 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |